Redox interactions-induced cardiac toxicity in cancer therapy
- PMID: 34097901
- DOI: 10.1016/j.abb.2021.108952
Redox interactions-induced cardiac toxicity in cancer therapy
Abstract
Cancer patients undergoing radiotherapy, chemotherapy, or targeted cancer therapy are exposed to the risk of several side effects because of the heavy production of ROS by ionizing radiation or some chemotherapy drugs. Damages to DNA, mitochondria, membrane and other organelles within normal tissue cells such as cardiomyocytes and endothelial cells lead to the release of some toxins which are associated with triggering inflammatory cells to release several types of cytokines, chemokines, ROS, and RNS. The release of some molecules following radiotherapy or chemotherapy stimulates reduction/oxidation (redox) reactions. Redox reactions cause remarkable changes in the level of reactive oxygen species (ROS) and reactive nitrogen species (RNS). Excessive production of ROS and RNS or suppression of antioxidant defense enzymes leads to damage to critical macromolecules, which may continue for long times. Increased levels of some cytokines and oxidative injury are hallmarks of heart injury following cancer therapy. Redox reactions may be involved in several heart disorders such as fibrosis, cardiomyopathy, and endothelium injury. In the current review, we explain the cellular and molecular mechanisms of redox interactions following radiotherapy, chemotherapy, and targeted cancer therapy. Afterward, we explain the evidence of the involvement of redox reactions in heart diseases.
Keywords: Cancer therapy; Cardiomyopathy; Chemotherapy; Endothelial dysfunction; Heart; Radiotherapy; Redox.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
Reduction-oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics.Clin Transl Oncol. 2018 Aug;20(8):975-988. doi: 10.1007/s12094-017-1828-6. Epub 2018 Jan 9. Clin Transl Oncol. 2018. PMID: 29318449 Review.
-
Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseases.Curr Med Chem. 2011;18(15):2272-314. doi: 10.2174/092986711795656081. Curr Med Chem. 2011. PMID: 21517751 Review.
-
Antioxidant Approach as a Cardioprotective Strategy in Chemotherapy-Induced Cardiotoxicity.Antioxid Redox Signal. 2021 Mar 1;34(7):572-588. doi: 10.1089/ars.2020.8055. Epub 2020 Apr 9. Antioxid Redox Signal. 2021. PMID: 32151144 Review.
-
Effects of anticancer drugs on the cardiac mitochondrial toxicity and their underlying mechanisms for novel cardiac protective strategies.Life Sci. 2021 Jul 15;277:119607. doi: 10.1016/j.lfs.2021.119607. Epub 2021 May 13. Life Sci. 2021. PMID: 33992675 Review.
-
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease.Arch Toxicol. 2016 Jan;90(1):1-37. doi: 10.1007/s00204-015-1579-5. Epub 2015 Sep 7. Arch Toxicol. 2016. PMID: 26343967 Review.
Cited by
-
The Metformin Immunoregulatory Actions in Tumor Suppression and Normal Tissues Protection.Curr Med Chem. 2024;31(33):5370-5396. doi: 10.2174/0929867331666230703143907. Curr Med Chem. 2024. PMID: 37403391 Review.
-
Mechanisms of Bleomycin-induced Lung Fibrosis: A Review of Therapeutic Targets and Approaches.Cell Biochem Biophys. 2024 Sep;82(3):1845-1870. doi: 10.1007/s12013-024-01384-9. Epub 2024 Jul 2. Cell Biochem Biophys. 2024. PMID: 38955925 Review.
-
Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents.Inflammopharmacology. 2022 Feb;30(1):73-89. doi: 10.1007/s10787-021-00894-9. Epub 2021 Nov 23. Inflammopharmacology. 2022. PMID: 34813027 Review.
-
Emerging mitochondrial signaling mechanisms in cardio-oncology: beyond oxidative stress.Am J Physiol Heart Circ Physiol. 2022 Oct 1;323(4):H702-H720. doi: 10.1152/ajpheart.00231.2022. Epub 2022 Aug 5. Am J Physiol Heart Circ Physiol. 2022. PMID: 35930448 Free PMC article. Review.
-
Cardiac Remodelling Following Cancer Therapy: A Review.Cardiovasc Toxicol. 2022 Sep;22(9):771-786. doi: 10.1007/s12012-022-09762-6. Epub 2022 Jul 25. Cardiovasc Toxicol. 2022. PMID: 35877038 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources